Poor inhaler technique is found to be especially prevalent among pMDI users, with only about 20% of patients and less than one-half of healthcare providers using pMDIs correctly even with training.6 7 ...

An increasing body of work suggests that pressurised metered dose inhalers with spacers (pMDI-S) are as effective. This study aims to investigate the effect on admission rates, total time in the ED, ...

Methods and Aim We performed a post-hoc analysis on clinical outcomes data from a 12-week real-world, non-interventional single arm study 1 of adult patients with asthma, COPD or asthma COPD overlap ...

Pressurised metered dose inhalers (pMDI) delivering drugs for asthma, chronic obstructive pulmonary disease and other respiratory diseases currently use hydrofluorocarbon (HFC) propellants that ...

Introduction: Because of environmental concerns, the use of chlorofluorocarbons in pressurised metered dose inhalers (pMDI) is being phased out. Innovata Biomed Ltd has developed an alternative ...

Soft mist inhalers (Respimat) are propellant-free and potentially reusable, reducing their environmental impact. Aims Compare product carbon footprints (PCFs) of disposable Respimat and HFA pMDI ...

RPC Formatec (Mellrichstadt / Germany; www.rpc-formatec.de) has introduced a new pressurised metered dose inhaler (PMDI) that counts down the number of doses taken from the device. Thanks to the ...

Anaesthetic gases and inhalers are often highlighted as particularly problematic ... Summary of key results: Carbon footprint and carbon values for standard and carbon minimal pmdi Notes: results ‘per ...

Presspart, a division of the Heitkamp & Thumann Group, has launched a new sub-micron plasma process for coating and treating the internal surfaces of pMDI canisters. Presspart plasma coating and ...

where DPIs are the predominant form of inhaler, patients have few problems using them, whereas in the UK, patients are unfamiliar with DPIs given their relative scarcity and so prefer pMDI options.

Each resident team had autonomy to decide how they approach the problem (e.g., switch inhaler device, check for diagnostic lung function testing and deprescribe where possible). Each month, metrics on ...